MCL-376: Benefits of Rituximab Maintenance After First-Line Bendamustine-Rituximab in Mantle Cell Lymphoma: A Meta-Analysis of Clinical Trials and Observational Studies
Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Institutions: Mayo Clinic, Mayo Clinic Hospital, Mayo Clinic in Florida
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204706472
